Z
Zimo Jia
Researcher at Hebei Medical University
Publications - 5
Citations - 63
Zimo Jia is an academic researcher from Hebei Medical University. The author has contributed to research in topics: Gene & microRNA. The author has an hindex of 2, co-authored 2 publications receiving 5 citations.
Papers
More filters
Journal ArticleDOI
LncRNA FAM83A-AS1 promotes ESCC progression by regulating miR-214/CDC25B axis.
Jinlin Jia,Hongle Li,Jie Chu,Jinxiu Sheng,Chang Wang,Zimo Jia,Weiwei Meng,Huiqing Yin,Junhu Wan,Fucheng He +9 more
TL;DR: In this paper, the expression pattern and the biological function of FAM83A-AS1 in esophageal cell squamous carcinoma (ESCC) were assessed by qRT-PCR and rescue assays.
Journal ArticleDOI
LncRNA MIR205HG Drives Esophageal Squamous Cell Carcinoma Progression by Regulating miR-214/SOX4 Axis
Hongle Li,Jinlin Jia,Lijun Yang,Jie Chu,Jinxiu Sheng,Chang Dong Wang,Weiwei Meng,Zimo Jia,Huiqing Yin,Junhu Wan,Fucheng He +10 more
TL;DR: Wang et al. as mentioned in this paper used qRT-PCR to detect the expression level of MIR205HG, miR-214 and SOX4 in human esophageal squamous cell carcinoma (ESCC) tissues and cell lines.
Journal ArticleDOI
Crosstalk of Exosomal Non-Coding RNAs in The Tumor Microenvironment: Novel Frontiers
TL;DR: Recent literature around the topic of the functions and mechanisms of exosomal ncRNAs in the TME are summarized and their clinical significance is highlighted.
Journal ArticleDOI
Novel insights into m6A modification of coding and non-coding RNAs in tumor biology: From molecular mechanisms to therapeutic significance
Jinling Jia,Su-Yao Wu,Zimo Jia,Chang Wang,Chenxi Ju,Jinxiu Sheng,Fucheng He,Mingxia Zhou,Jing He +8 more
TL;DR: Current advances in m 6A modification and the regulatory mechanisms underlying mRNAs and ncRNAs in distinct cancer stages are highlighted and the therapeutic significance of m6A regulators in clinical cancer treatment is focused on.
Journal ArticleDOI
Non-Coding RNAs in Colorectal Cancer: Their Functions and Mechanisms
TL;DR: This review details strategies that trigger the recognition of CRC-related ncRNAs, as well as the methodologies and challenges of studying these molecules, and the forthcoming clinical applications of these findings.